These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 4019774

  • 21. Differences in the neuronal removal of circulating epinephrine and norepinephrine.
    Eisenhofer G, Esler MD, Cox HS, Meredith IT, Jennings GL, Brush JE, Goldstein DS.
    J Clin Endocrinol Metab; 1990 Jun; 70(6):1710-20. PubMed ID: 2347902
    [Abstract] [Full Text] [Related]

  • 22. Norepinephrine kinetics in essential hypertension. Defective neuronal uptake of norepinephrine in some patients.
    Esler M, Jackman G, Bobik A, Leonard P, Kelleher D, Skews H, Jennings G, Korner P.
    Hypertension; 1981 Jun; 3(2):149-56. PubMed ID: 7216371
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Differentiated norepinephrine spillover in human skeletal muscle.
    Karlsson AK, Elam M, Lönnroth P, Sullivan L, Friberg P.
    Am J Physiol; 1997 Jul; 273(1 Pt 2):R16-21. PubMed ID: 9249527
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Different desipramine-sensitive pulmonary removals of plasma epinephrine and norepinephrine in dogs.
    Eisenhofer G, Smolich JJ, Esler MD.
    Am J Physiol; 1992 Mar; 262(3 Pt 1):L360-5. PubMed ID: 1550259
    [Abstract] [Full Text] [Related]

  • 27. Determination of noradrenaline uptake, spillover to plasma and plasma concentration in patients with essential hypertension.
    Esler M, Jackman G, Leonard P, Bobik A, Skews H, Jennings G, Kelleher D, Korner P.
    Clin Sci (Lond); 1980 Dec; 59 Suppl 6():311s-313s. PubMed ID: 7449275
    [Abstract] [Full Text] [Related]

  • 28. Phenotypic evidence of faulty neuronal norepinephrine reuptake in essential hypertension.
    Rumantir MS, Kaye DM, Jennings GL, Vaz M, Hastings JA, Esler MD.
    Hypertension; 2000 Nov; 36(5):824-9. PubMed ID: 11082150
    [Abstract] [Full Text] [Related]

  • 29. Estimation of sympathetic activity in essential hypertension.
    Brown MJ, Lhoste FJ, Zamboulis C, Ind PW, Jenner DA, Dollery CT.
    Clin Pharmacol Ther; 1982 Jan; 31(1):16-22. PubMed ID: 7053299
    [Abstract] [Full Text] [Related]

  • 30. Norepinephrine metabolism in humans. Kinetic analysis and model.
    Linares OA, Jacquez JA, Zech LA, Smith MJ, Sanfield JA, Morrow LA, Rosen SG, Halter JB.
    J Clin Invest; 1987 Nov; 80(5):1332-41. PubMed ID: 3316275
    [Abstract] [Full Text] [Related]

  • 31. Comparison of noradrenaline and isoprenaline removal in the canine hindlimb and kidney.
    Zimlichman R, Goldstein DS, Eisenhofer G, Stull R, Keiser HR.
    Clin Exp Pharmacol Physiol; 1986 Nov; 13(11-12):777-81. PubMed ID: 3829445
    [Abstract] [Full Text] [Related]

  • 32. Plasma catecholamine and hemodynamic responses during isoproterenol infusions in humans.
    Goldstein DS, Zimlichman R, Stull R, Keiser HR.
    Clin Pharmacol Ther; 1986 Aug; 40(2):233-8. PubMed ID: 3731686
    [Abstract] [Full Text] [Related]

  • 33. Estimation of intrasynaptic norepinephrine concentrations at vascular neuroeffector junctions in vivo.
    Kopin IJ, Zukowska-Grojec Z, Bayorh MA, Goldstein DS.
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Apr; 325(4):298-305. PubMed ID: 6728040
    [Abstract] [Full Text] [Related]

  • 34. Plasma norepinephrine in humans: limitations in assessment of whole body norepinephrine kinetics and plasma clearance.
    Henriksen JH, Christensen NJ.
    Am J Physiol; 1989 Nov; 257(5 Pt 1):E743-50. PubMed ID: 2596601
    [Abstract] [Full Text] [Related]

  • 35. Continuous infusion of tracer norepinephrine may miscalculate unidirectional nerve uptake of norepinephrine in humans.
    Henriksen JH, Christensen NJ, Ring-Larsen H.
    Circ Res; 1989 Aug; 65(2):388-95. PubMed ID: 2752547
    [Abstract] [Full Text] [Related]

  • 36. The effect of sodium depletion on plasma norepinephrine kinetics in patients with essential hypertension.
    Kimura S, Miura Y, Adachi M, Adachi M, Nezu M, Toriyabe S, Sugawara T, Ishizuka Y, Noshiro T, Takahashi M.
    Jpn Circ J; 1983 Oct; 47(10):1232-41. PubMed ID: 6632176
    [Abstract] [Full Text] [Related]

  • 37. Haemodynamics as a determinant of the pharmacokinetics of and the plasma catecholamine responses to isoprenaline.
    Ludwig J, Halbrügge T, Vey G, Walter J, Graefe KH.
    Eur J Clin Pharmacol; 1989 Oct; 37(5):493-500. PubMed ID: 2598988
    [Abstract] [Full Text] [Related]

  • 38. Clinical aspects on presynaptic noradrenaline metabolism.
    Ludwig J, Halbrügge T, Graefe KH.
    J Neural Transm Suppl; 1991 Oct; 34():69-75. PubMed ID: 1817166
    [Abstract] [Full Text] [Related]

  • 39. Assessment of neuronal uptake of noradrenaline in humans: defective uptake in some patients with essential hypertension.
    Esler M, Leonard P, Kelleher D, Jackman G, Bobik A, Skews H, Jennings G, Korner P.
    Clin Exp Pharmacol Physiol; 1980 Oct; 7(5):535-9. PubMed ID: 7449197
    [Abstract] [Full Text] [Related]

  • 40. Age-dependent changes of cardiac neuronal noradrenaline reuptake transporter (uptake1) in the human heart.
    Leineweber K, Wangemann T, Giessler C, Bruck H, Dhein S, Kostelka M, Mohr FW, Silber RE, Brodde OE.
    J Am Coll Cardiol; 2002 Oct 16; 40(8):1459. PubMed ID: 12392837
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.